UBS Group’s Bioventus BVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $583K | Sell |
63,896
-17,769
| -22% | -$149K | ﹤0.01% | 5974 |
|
|
2025
Q4 | $608K | Buy |
81,665
+9,705
| +13% | +$69.8K | ﹤0.01% | 5961 |
|
|
2025
Q3 | $481K | Sell |
71,960
-15,653
| -18% | -$109K | ﹤0.01% | 6118 |
|
|
2025
Q2 | $580K | Buy |
87,613
+41,441
| +90% | +$294K | ﹤0.01% | 5884 |
|
|
2025
Q1 | $422K | Buy |
46,172
+7,682
| +20% | +$76.7K | ﹤0.01% | 5984 |
|
|
2024
Q4 | $404K | Buy |
38,490
+4,114
| +12% | +$48.7K | ﹤0.01% | 5991 |
|
|
2024
Q3 | $411K | Buy |
34,376
+21,600
| +169% | +$187K | ﹤0.01% | 5364 |
|
|
2024
Q2 | $73.5K | Buy |
12,776
+11,471
| +879% | +$62.9K | ﹤0.01% | 6395 |
|
|
2024
Q1 | $6.79K | Sell |
1,305
-1,071
| -45% | -$5.23K | ﹤0.01% | 7435 |
|
|
2023
Q4 | $12.5K | Sell |
2,376
-1,902
| -44% | -$7.53K | ﹤0.01% | 7347 |
|
|
2023
Q3 | $14.1K | Buy |
4,278
+2,469
| +136% | +$8.66K | ﹤0.01% | 6967 |
|
|
2023
Q2 | $5.23K | Sell |
1,809
-13,918
| -88% | -$26.7K | ﹤0.01% | 7461 |
|
|
2023
Q1 | $16.8K | Buy |
15,727
+2,983
| +23% | +$5.71K | ﹤0.01% | 7210 |
|
|
2022
Q4 | $33.3K | Buy |
12,744
+5,372
| +73% | +$23.5K | ﹤0.01% | 7132 |
|
|
2022
Q3 | $51K | Buy |
7,372
+3,462
| +89% | +$27.1K | ﹤0.01% | 6332 |
|
|
2022
Q2 | $27K | Sell |
3,910
-1,198
| -23% | -$12.2K | ﹤0.01% | 6501 |
|
|
2022
Q1 | $72K | Sell |
5,108
-8,485
| -62% | -$114K | ﹤0.01% | 6145 |
|
|
2021
Q4 | $197K | Buy |
+13,593
| New | +$193K | ﹤0.01% | 5707 |
|
|
2021
Q3 | – | Sell |
-1,753
| Closed | -$31K | – | 9558 |
|
|
2021
Q2 | $31K | Sell |
1,753
-2,535
| -59% | -$40.9K | ﹤0.01% | 6877 |
|
|
2021
Q1 | $66K | Buy |
+4,288
| New | +$61.1K | ﹤0.01% | 6275 |
|
Other funds holding BVS
EWM
JIC
NCM
VCM
RA
VPM
